Nurix Therapeutics (NRIX)
(Delayed Data from NSDQ)
$13.75 USD
-0.38 (-2.69%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $13.76 +0.01 (0.07%) 6:48 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 7/11/24 |
---|---|
Current Quarter | -0.72 |
EPS Last Quarter | -0.76 |
Last EPS Surprise | 5.00% |
ABR | 1.36 |
Earnings ESP
|
3.50% |
---|---|
Current Year | -3.15 |
Next Year | -3.28 |
EPS (TTM) | -2.66 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (5/2024) |
Next Qtr (8/2024) |
Current Year (11/2024) |
Next Year (11/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 19.35M | 15.84M | 64.71M | 63.76M |
# of Estimates | 6 | 6 | 6 | 5 |
High Estimate | 28.73M | 20.00M | 76.60M | 80.00M |
Low Estimate | 13.50M | 11.96M | 57.09M | 55.00M |
Year ago Sales | 30.68M | 18.47M | 76.99M | 64.71M |
Year over Year Growth Est. | -36.92% | -14.23% | -15.94% | -1.48% |
Earnings Estimates
Current Qtr (5/2024) |
Next Qtr (8/2024) |
Current Year (11/2024) |
Next Year (11/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.72 | -0.75 | -3.15 | -3.28 |
# of Estimates | 6 | 6 | 5 | 5 |
Most Recent Consensus | -0.85 | -0.88 | -3.46 | NA |
High Estimate | -0.47 | -0.64 | -2.87 | -2.44 |
Low Estimate | -0.89 | -0.88 | -3.53 | -4.93 |
Year ago EPS | -0.45 | -0.68 | -2.65 | -3.15 |
Year over Year Growth Est. | -60.00% | -10.29% | -18.87% | -4.13% |
Agreement - Estimate Revisions
Current Qtr (5/2024) |
Next Qtr (8/2024) |
Current Year (11/2024) |
Next Year (11/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | 1 | 1 |
Up Last 30 Days | 4 | 3 | 3 | 3 |
Up Last 60 Days | 4 | 3 | 3 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 2 | 1 | 2 |
Down Last 60 Days | 1 | 2 | 1 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (5/2024) |
Next Qtr (8/2024) |
Current Year (11/2024) |
Next Year (11/2025) |
|
---|---|---|---|---|
Current | -0.72 | -0.75 | -3.15 | -3.28 |
7 Days Ago | -0.75 | -0.79 | -3.31 | -3.47 |
30 Days Ago | -0.84 | -0.78 | -3.34 | -3.46 |
60 Days Ago | -0.84 | -0.78 | -3.34 | -3.46 |
90 Days Ago | -0.86 | -0.86 | -3.40 | -3.61 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (5/2024) |
Next Qtr (8/2024) |
Current Year (11/2024) |
Next Year (11/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.70 | -0.72 | -3.07 | -3.28 |
Zacks Consensus Estimate | -0.72 | -0.75 | -3.15 | -3.28 |
Earnings ESP | 3.50% | 3.57% | 2.50% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (2/2024) |
Quarter Ending (11/2023) |
Quarter Ending (8/2023) |
Quarter Ending (5/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.76 | -0.77 | -0.68 | -0.45 | NA |
Estimate | -0.80 | -0.51 | -0.69 | -0.63 | NA |
Difference | 0.04 | -0.26 | 0.01 | 0.18 | -0.01 |
Surprise | 5.00% | -50.98% | 1.45% | 28.57% | -3.99% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more